Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8849 |
High Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8794 |
High Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8582 |
High Similarity |
NPD1510 |
Phase 2 |
0.8311 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8311 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8311 |
Intermediate Similarity |
NPD2532 |
Approved |
0.831 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8298 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8276 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8235 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8207 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8207 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8188 |
Intermediate Similarity |
NPD1470 |
Approved |
0.8188 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8069 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.8042 |
Intermediate Similarity |
NPD943 |
Approved |
0.8041 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8041 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8039 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8038 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8014 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8013 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7987 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7986 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7985 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7973 |
Intermediate Similarity |
NPD2800 |
Approved |
0.795 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7947 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7935 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7899 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7898 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7834 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.777 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7756 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7742 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7736 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7736 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7703 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7687 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7658 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7654 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7654 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7647 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7625 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7613 |
Intermediate Similarity |
NPD920 |
Approved |
0.761 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7609 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7595 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.758 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7576 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7566 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7562 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7561 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7533 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7533 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7533 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7533 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7533 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7533 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7533 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7531 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7484 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7483 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7464 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7455 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7455 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7455 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7425 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7425 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7415 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7391 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7386 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7378 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7362 |
Intermediate Similarity |
NPD919 |
Approved |
0.7343 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7337 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7337 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7321 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7314 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7297 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7294 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7294 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.729 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7278 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7278 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7262 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7261 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7255 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7251 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7251 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7251 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7226 |
Intermediate Similarity |
NPD1609 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7192 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7192 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7186 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7184 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7181 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7181 |
Intermediate Similarity |
NPD411 |
Approved |
0.7161 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7153 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7152 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7143 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7118 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7115 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7113 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7102 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7073 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7067 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD37 |
Approved |
0.7055 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7048 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7039 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7039 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7035 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7034 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7034 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7033 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7033 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7033 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7033 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7033 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7033 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7033 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7033 |
Intermediate Similarity |
NPD6776 |
Approved |
0.703 |
Intermediate Similarity |
NPD4965 |
Approved |
0.703 |
Intermediate Similarity |
NPD4966 |
Approved |
0.703 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7027 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD3300 |
Phase 2 |
0.7014 |
Intermediate Similarity |
NPD2932 |
Approved |
0.7007 |
Intermediate Similarity |
NPD74 |
Approved |
0.7007 |
Intermediate Similarity |
NPD9266 |
Approved |
0.7006 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7005 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.6975 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6962 |
Remote Similarity |
NPD6190 |
Approved |
0.6957 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD4750 |
Phase 3 |
0.6954 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6934 |
Remote Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.6934 |
Remote Similarity |
NPD9267 |
Approved |
0.6934 |
Remote Similarity |
NPD9263 |
Approved |
0.6934 |
Remote Similarity |
NPD9264 |
Approved |
0.6933 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6933 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6928 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6923 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6919 |
Remote Similarity |
NPD7697 |
Approved |
0.6919 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6919 |
Remote Similarity |
NPD7698 |
Approved |
0.6919 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6914 |
Remote Similarity |
NPD8313 |
Approved |
0.6914 |
Remote Similarity |
NPD8312 |
Approved |
0.6903 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6903 |
Remote Similarity |
NPD3299 |
Clinical (unspecified phase) |
0.6899 |
Remote Similarity |
NPD7003 |
Approved |
0.6897 |
Remote Similarity |
NPD3019 |
Approved |
0.6897 |
Remote Similarity |
NPD3658 |
Clinical (unspecified phase) |
0.6893 |
Remote Similarity |
NPD8434 |
Phase 2 |
0.6892 |
Remote Similarity |
NPD1283 |
Approved |
0.6892 |
Remote Similarity |
NPD1876 |
Approved |
0.6882 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6882 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6871 |
Remote Similarity |
NPD3972 |
Approved |
0.6871 |
Remote Similarity |
NPD1608 |
Approved |
0.6871 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6851 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.6851 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6842 |
Remote Similarity |
NPD3268 |
Approved |
0.6832 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6828 |
Remote Similarity |
NPD1651 |
Approved |
0.6824 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6816 |
Remote Similarity |
NPD4287 |
Approved |
0.6813 |
Remote Similarity |
NPD4361 |
Phase 2 |
0.6813 |
Remote Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.6807 |
Remote Similarity |
NPD5761 |
Phase 2 |
0.6807 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.68 |
Remote Similarity |
NPD1019 |
Discontinued |
0.6797 |
Remote Similarity |
NPD520 |
Approved |
0.6796
|
Remote Similarity |
NPD6212 |
Phase 3 |